Levels of neuronal pentraxin 2 in plasma is associated with cognitive function in patients with schizophrenia.
Rationale: The precise diagnosis and treatment of cognitive impairment remains a major challenge in the field of schizophrenia (SCZ) research. Synaptic dysfunction and loss are thought to be closely related to the occurrence and development of SCZ and may be involved in cognitive dysfunction. Object...
| Published in: | Psychopharmacology Vol. 241; no. 4; pp. 865 - 875 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Apr2024
|
| Online Access: | View this record in EBSCOhost |